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To investigate the cell-intrinsic aging mechanisms
that erode the function of somatic stem cells during
aging, we have conducted a comprehensive inte-
grated genomic analysis of young and aged cells.
We profiled the transcriptome, DNA methylome,
and histone modifications of young and old murine
hematopoietic stem cells (HSCs). Transcriptome
analysis indicated reduced TGF-b signaling and
perturbation of genes involved in HSC proliferation
and differentiation. Aged HSCs exhibited broader
H3K4me3 peaks across HSC identity and self-
renewal genes and showed increased DNA methyl-
ation at transcription factor binding sites associated
with differentiation-promoting genes combined with
a reduction at genes associated with HSC mainte-
nance. Altogether, these changes reinforce HSC
self-renewal and diminish differentiation, paralleling
phenotypic HSC aging behavior. Ribosomal biogen-
esis emerged as a particular target of aging with
increased transcription of ribosomal protein and
RNA genes and hypomethylation of rRNA genes.
This data set will serve as a reference for future epi-
genomic analysis of stem cell aging.
INTRODUCTION
The function of the hematopoietic system declines with age,
manifested by a decreased adaptive immune response and anincreased incidence of myeloproliferative diseases, autoim-
mune, and inflammatory disorders (Linton and Dorshkind,
2004; Ramos-Casals et al., 2003). Although some extrinsic
cellular factors such as an inflammatory microenvironment
promote aging (Ergen et al., 2012; Villeda et al., 2011), these
impact the hematopoietic stem cells (HSCs), causing cell-
intrinsic changes that affect the generation of a balanced supply
of differentiated blood lineages.
Multiple lines of investigation have established that, with age,
phenotypically defined mouse and human HSCs increase in
number, whereas lymphoid cell production is diminished, lead-
ing to a myeloid-dominant hematopoietic system (Chambers
et al., 2007b; de Haan and Van Zant, 1999; Morrison et al.,
1996; Rossi et al., 2005). The myeloid dominance is caused
partly by a shift in the clonal composition of the HSC compart-
ment (Beerman et al., 2010; Challen et al., 2010; Cho et al.,
2008) but also reflects diminished differentiation capacity of indi-
vidual HSCs (Dykstra et al., 2011).
Mechanisms proposed to account for the age-related loss
of HSC function include telomere shortening, accumulation of
nuclear and mitochondrial DNA damage (Wang et al., 2012),
and coordinated variation in gene expression. Analysis of
young and old HSCs revealed that genes associated with inflam-
mation and stress response were upregulated, and genes
involved in DNA repair and chromatin silencing were downregu-
latedwith HSC aging (Chambers et al., 2007b; Rossi et al., 2005).
These earlier studies were conducted on HSC populations that
proved to be heterogeneous and therefore represented a mix
of cellular phenotypes. Here, we examined highly purified
HSCs and tested whether the concept that loss of epigenetic
regulation of gene expression in aged HSCs could explain the
constellation of aging phenotypes. We completed genome-
wide comparisons of the transcriptome (RNA sequencingCell Stem Cell 14, 673–688, May 1, 2014 ª2014 Elsevier Inc. 673
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Epigenome Dysregulation in Aging HSCs[RNA-seq]), histone modification (chromatin immunoprecipita-
tion sequencing [ChIP-seq]), and DNA methylation between
young and old purified murine bone marrow HSCs. This report
presents an integrated analysis of these genomic properties,
reveals potential mechanisms that contribute to HSC aging,
and offers a comprehensive reference epigenome of a somatic
stem cell type. Finally, it reveals similarities with some common
hallmarks of aging (Lo´pez-Otı´n et al., 2013) previously noted
in model organisms such as Caenorhabditis elegans and
Drosophila melanogaster but not yet examined in mammals.
RESULTS
Alterations in Gene Expression with Age
Because previous analyses of gene expression changes with
age utilized HSC populations that are now known to be hetero-
geneous with regard to lymphoid versus myeloid production
proficiency, we utilized the most primitive HSCs with the highest
long-term self-renewal potential, which are considered myeloid
biased (or lymphoid deficient). HSCs throughout this study
were purified as side population (SP)-KLS (c-kit+, lineage–, and
Sca1+)-CD150+ (see the Experimental Procedures) because
these are found in both young and aged mice and have high
phenotypic homogeneity and functional activity (Challen et al.,
2010; Mayle et al., 2013). High-throughput sequencing of poly A+
RNA (RNA-seq) from purified 4-month- (4mo) and 24 month-old
(24mo) HSCs was performed. With biological duplicates, more
than 200 million reads in total for each age of HSC were
obtained, offering high sensitivity for detecting gene expression
differences in young and aged HSCs.
Comparison of the young and old HSC transcriptomes
revealed that 1,337 genes were upregulated and 1,297 were
downregulated with HSC aging (false discovery rate [FDR] <
0.05; Table S1 available online). Aging HSC hallmark genes
Clusterin (Clu) and P-selectin (Selp) (Chambers et al., 2007b)
were markedly upregulated, although their expression was also
detectable in in young HSCs, demonstrating the sensitivity of
RNA-seq.
Gene ontology (GO) analyses indicated that genes upregu-
lated in 24mo HSCs are highly enriched in categories related to
cell adhesion, cell proliferation, and the ribosome, whereas
downregulated genes are enriched in DNA base excision repair,
DNA replication, and cell cycle (Figure 1A). Gene set enrichment
analysis with the Molecular Signature Database as well as
several customized HSC, myeloid, and lymphoid gene sets
(‘‘fingerprint’’ genes; Table S2) (Chambers et al., 2007a) revealed
that HSC-specific genes as a group were upregulated in old
HSCs, in agreement with their increased phenotypic stem cell
characteristics. Cell cycle, DNA replication, and glutamate
signaling were also differentially expressed gene sets.
TheAging HSCTranscriptome Suggests Reduced TGF-b
Signaling
Next, we sought to infer the key regulators responsible for
transcriptional changes in aging HSCs. We performed a
functional enrichment analysis on the basis of expected cause-
effect relationships between transcriptional regulators and
their targets in the Ingenuity Pathway Analysis (IPA) database.
The most highly represented upstream regulator was growth674 Cell Stem Cell 14, 673–688, May 1, 2014 ª2014 Elsevier Inc.factor TGF-b1, accounting for 19% of differential gene ex-
pression in young versus old HSCs (p = 1.96 3 1033;
Table S3). In comparison to all genes affected by age, TGF-
b-regulated genes were five times more likely to be altered in
expression than expected by chance (p = 3.53 3 1020). As a
group, 63% (136 of 217) of TGF-b1 downstream genes were
associated with a diversity of biological functions supporting
hematopoiesis (n = 83, p = 4.56 3 1024 to 1.29 3 109) and/or
are corroborated by earlier microarray-based studies of HSC
aging (n = 86; Table S3).
Depending on the context, TGF-b factors exert pleiotropic,
and sometimes opposing, cellular effects. If TGF-b1 signaling
were inhibited, then we would expect key intermediary tran-
scription factors (TFs) to be similarly affected. To test this, we
constructed a network of cooperating regulators that are
connected downstream of TGF-b1 by one edge. This analysis
identified Smad3, Sp1, and Egr1 and predicted that they were
inhibited during HSC aging (Figure S1 and Table S3). Indeed,
expression of Egr1, a regulator of HSC homeostasis (Min et al.,
2008), is significantly reduced with aging. Additional groups of
genes normally activated by TGF-b are of interest. Seven
collagen and three metalloproteinase (mmp) genes, implicated
in HSC-niche interactions, were downregulated. In addition,
expression of TGF-b-regulated genes involved in HSC develop-
ment, such as Nr4a1, Cepba, Jun, and Junb, was reduced.
Reduction of several of these targets could contribute to myeloid
differentiation bias.
Of genes upregulated with aging, one notable class was
ribosomal protein genes, including a majority of those encoding
both the large (Rpl) and small (Rps) subunits (Figure 1B), but not
mitochondrial ribosomal protein groups (Mrpl and Mrps;
confirmed by exon arrays; Figure S2A). Upregulation of genes
involved in protein synthesis has been previously noted with
aging. Indeed, inhibition of ribosomal proteins or their regulators
has been shown to extend lifespan in yeast and worms (Kaeber-
lein et al., 2005; Syntichaki et al., 2007). However, changes in the
expression of ribosomal protein genes have not been previously
reported in mammalian stem cells.
Expression of Key Epigenetic Regulators Decreases
with Age
Because we hypothesized that epigenetic regulation plays a
role in HSC aging, we examined expression of epigenetic
modifiers (Figure 1C). Ezh1 showed increased expression,
consistent with previous findings (Hidalgo et al., 2012). In
contrast, Ezh2 and the polycomb group (PcG) complex member
Cbx2 decreased in old HSCs. In addition, expression of histone
kinase genesAurka and Aurkb, putative Ezh2 partners, or targets
(Kamminga et al., 2006) also decreased with age.
Genes encoding DNA methyltransferases as a group
decreased during aging (FDR = 0.02; Figure 1C and Table S2).
Concomitantly, genes encoding Tet1 and Tet3 DNA demethyla-
tion proteins were also decreased. Although their functions are
unknown, Tet2 mutation leads to expansion of hematopoietic
progenitors and increased stem cell self-renewal (Ko et al.,
2011; Li et al., 2011; Moran-Crusio et al., 2011; Quivoron et al.,
2011), and TET2 is recurrently mutated in myelodysplastic
syndrome (MDS) and acute myeloid lymphoma (AML) patients
(Delhommeau et al., 2009; Langemeijer et al., 2009). Consistent
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Figure 1. Transcriptome Alterations with HSC Aging
(A) Gene ontology (GO) enrichment analysis for differentially expressed genes with HSC aging. The x axis shows the p value.
(B) The distribution of expression changes for ribosomal protein genes during HSC aging where the x axis value is fragments per kilobase of exon per million
fragments mapped (FPKM) difference between old and young HSCs.
(C) Average FPKM value of genes encoding epigenetic modifiers in young and old HSCs.
(D) HPLC mass spectrometry measurements of 5-hydroxy methylcytosine (5hmc) levels as a proportion of the total cytosine in purified HSCs from 4mo, 12mo,
and 24mo mice (n = 7). Error bars represent mean ± SEM. **p < 0.01 and ***p < 0.005 (Student’s t test).
(E) Differential expression of repetitive elements during HSC aging. Each row represents a repeat location in the genome. Blue denotes low expression, and yellow
high expression (log2 reads number).
See also Figures S1 and S2.
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trometry revealed reduced 5-hydroxymethycytosine with age
(Figure 1D).Repetitive elements are epigenetically repressed, so we
examined whether they were dysregulated with aging. Strikingly,
the RNA-seq data revealed marked changes in the expression ofCell Stem Cell 14, 673–688, May 1, 2014 ª2014 Elsevier Inc. 675
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Figure 2. Histone Marks in HSC
(A) Heatmap and profile of H3K4me3 around TSS of all RefSeq genes. Red represents high intensity, andwhite represents no signal. Cluster IDs aremarked to the
left. The profile plot shows the average reads per region on the y axis at each relative position to TSS on the x axis for the four clusters with H3K4me3 coverage.
(B) Heat map and profile of H3K27me3 around the gene body of all RefSeq genes. The profile plot shows the average reads per region on y axis at each relative
position on the x axis for the three clusters with H3K27me3 coverage. All genes are normalized to same length.
(C) Heatmap and profile of H3K36me3 around the gene body of all RefSeq genes. The profile plot shows the average reads per region on the y axis at each relative
position on the x axis for the four clusters with H3K36me3 coverage. All genes are normalized to same length.
(D) Unsupervised clustering of histone profiles around the TSS of the RefSeq genes showed bivalent genes marked by both H3K4me3 and H3K27me3 in HSCs.
(E) GO enrichment analysis for the bivalent genes in HSCs. p values and gene counts are shown.
(legend continued on next page)
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Epigenome Dysregulation in Aging HSCsmultiple repetitive elements with age, including 168 long terminal
repeat (LTR) elements, 113 long interspersed elements (LINEs),
67 short interspersed elements (SINEs), and 32 other repeat
elements. Of these, 68%76% exhibited increased expression.
This increased repetitive element expression may result
from aberrant epigenetic repression and could contribute to
increased genome instability (Figure 1E). Anomalous repetitive
element expression has been associated with embryonic stem
cells (ESCs) (Xie et al., 2013) but not aging. Examination of the
genes near the dysregulated LTR elements, LINEs, and SINEs
revealed 194, 127, and 72 genes, respectively. Functional
enrichment with the Genomic Regions Enrichment of Annota-
tions Tool indicated LINE- and SINE-associated genes were
enriched for these involved in hematological diseases such as
Cdc42, Flt3, and Lmo2 (Table S4).
Alterations in Transcript Isoform Expression
RNA-seq also revealed age-associated changes in promoter
usage and pre-mRNA abundance. We identified 118 genes
that showed switched promoter usage during aging (Table S4).
One example is Runx1t1, a locus translocated to RUNX1 in
some types of AML. The full-length Runx1t1 is expressed in
old HSCs, and the short isoform is expressed in young HSCs
(Figure S2B). Another example is Nfkbiz, with expression of the
short isoform decreased with aging (Figure S2C).
We previously noted that HSCs contain significant incom-
pletely spliced mRNA that is reduced when HSCs are activated
(Venezia et al., 2004). Global pre-mRNA quantification confirmed
a full 13% of reads within RefSeq introns in young HSCs, which
decreasedwith age (Figure S2D). Nearly 300 genes showed age-
associated alteration of pre-mRNA abundance. Of the 184 genes
with decreased pre-mRNA abundance, many were classified in
ribosome, immunoglobulin domain, and extracellular region
categories by GO analysis (for example, Ctla2a and ribosome
protein Rpl13; Figure S2E), whereas the 96 genes with increased
pre-mRNA were enriched in zinc-finger-encoding genes (Fig-
ure S2F). The decreased pre-mRNA with age may be associated
with increased translation.
HSC-Specific Chromatin Features
To examine epigenetic alterations, we profiled the principal
regulatory chromatin marks in HSCs, specifically H3K4me3,
H3K27me3 and H3K36me3 marks in young (4mo) and old
(24mo) HSCs with the use of ChIP-seq. Because these global
analyses have never been performed on such highly purified
HSCs, we first describe our general observations.
In young HSCs, 10,263 RefSeq genes had clear H3K4me3-
associated peaks. Clustering of the signal around the tran-
scription start site (TSS) show that the H3K4me3 peaks can be
classified into four distinct clusters (Figure 2A). Cluster 1 over-
laps with 2,373 genes and shows high intensity and wide
coverage (mean 3,200 bp) into the gene body. Cluster 2 (2,225
genes) and cluster 3 (5,665 genes) have similar intensity and
coverage lengths (2,000 bp), but cluster 2 has more coverage(F) The classification of RefSeq genes according to cobinding patterns of H3K4m
(G) Venn diagram showing the HSC genes that share the listed chromatin m
(H3K27me3) in differentiated B and Gr1 cells.
See also Figure S3.upstream of the TSS. The remaining RefSeq genes have little
or no discernible H3K4me3 peak (cluster 4).
For the repressive H3K27me3 mark in young HSCs, we iden-
tified 3,768 peaks present in the promoter region defined as
the TSS ± 1 kb. Unsupervised clustering showed the majority
with a sharp peak over the TSS (cluster 2; distinct from the
H3K4 clusters). A small subset showed high levels spread over
most of the coding region (cluster 1; Figure 2B). For
H3K36me3, the signals are depleted at the TSS and increase
from the TSS to the transcription termination site (Figure 2C).
As in other cell types, this mark was strongly correlated with
gene expression and enriched in the gene body. H3K36me3
and H3K27me3 signals were generally mutually exclusive
(Figure S3A).
Genes with both activating H3K4me3 and repressive
H3K27me3 were first identified in ESCs as so-called ‘‘bivalent’’
genes, thought to represent poised master regulators (Bernstein
et al., 2006). Here, 2,267 out of 3,768 H3K27me3-enriched genes
in HSC also contain H3K4me3 (Figure 2D), similar to the propor-
tions in ESCs (although we cannot confirm that the marks are on
the same allele). These genes were enriched for development,
transcriptional regulation, and RNA metabolism GO categories
(Figure 2E), consistent with previous observations (Weishaupt
et al., 2010). Many transcription factors important for hematopoi-
etic differentiation, such as Cebpa, Ebf-1, Pax5, and Gata3,
appeared bivalent. Notably, one-third of the bivalent HSC genes
are glycoproteins involved in signaling pathways such as Wnt,
Hedgehog, bone morphogenetic proteins, and TGF-b. Their
expression was generally low (Figure S3B).
Next, we attempted to identify potential HSC regulators on the
basis of histone modifications. We compared ESC H3K4me3
and H3K27me3 binding sites (Bernstein et al., 2006) with those
from HSCs as well as differentiated B cells and granulocytes
(Gr) (Figure 2F). We selected genes that were developmental
regulators (bivalent in ESCs) and were activated in HSCs
(H3K4me3 only) but were repressed upon HSC differentiation
(regained H3K27me3 in differentiated B cells and Gr) to identify
255 genes (Figure 2G and Table S5). These are enriched for
TFs and pathways in cancer (Figure S3C). Significantly, 20% of
them overlap with HSC fingerprint genes (Chambers et al.,
2007a), including Cd34, Gata2, and Meis1, whose functions in
HSCs have been demonstrated, showing that histone profiles
can independently predict key HSC regulators.
Aging-Associated Changes in Histone Marks
Next, we examined aging-associated histone mark changes.
Although most shifts were moderate, there were some unique
features. Old HSCs exhibited a 6.3% increase in the number of
H3K4me3 peaks, many of which were considerably broader
with age; more than half of all H3K4me3 peaks expanded, and
less than 10% shrank (Figure 3A). The expansion of H3K4me3
coverage was greatest for peaks already broad in young
HSCs; for peaks longer than 3 kb in young HSCs, there are
69% and 7% of lengthening and shortening events, respectivelye3 and H3K27me3 in HSCs and ESCs. Both, H3K4me3 with H3K27me3.
odifications: bivalent in ESCs, actively transcribed in HSCs, and repressed
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Figure 3. Histone Modifications Changes with HSC Aging
(A) Percent of H3K4me3 peaks getting longer or shorter (>200 bp) in old HSCs. The x axis is the peak length cutoff to be counted toward lengthening or shortening.
The y axis is the number of wider or shorter peaks divided by total number of peaks at the length cutoff. The circles represent the percent of lengthening (red) and
shortening (black) events.
(B) Heat map of H3K4me3 density around promoters that show significantly different H3K4me3 binding with age (Poisson p = 108).
(C) The correlation between gene expression andH3K4me3 signals for the significantly different H3K4me3 binding genes. The x axis denotes the log2 fold change
of H3K4me3 ChIP-seq read counts in the defined promoter region, and the y axis denotes the log2 fold change of FPKM value for the gene.
(legend continued on next page)
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Epigenome Dysregulation in Aging HSCs(Figure S3D). Peak expansion was particularly striking at genes
associated with HSC identity (Figure S3E).
More H3K4me3 coverage in old HSCs suggested that some
previously unexpressed transcripts are activated. The levels of
H3K4me3 were significantly increased on 267 promoters and
decreased on 73 promoters in the old HSCs (Figure 3B). We
observed a strong positive correlation between altered
H3K4me3 signal and gene expression changes (Figure 3C).
Increased H3K4me3 was observed for the most upregulated
genes, such as Selp, Nupr1, Sdpr, Plscr2, and Slamf1, and
genes in the HoxB cluster (Figure S3F). In addition, increased
H3K4me3 was associated with altered promoter usage, for
example, at the oxidation resistance 1 (Oxr1) gene, revealing
an unannotated promoter (Figure 3D).
PcG-mediated epigenetic alteration is considered a driving
force behind many age-related changes and is often dysregu-
lated in human malignancies. We observed similar H3K27me3
peak counts with age but increased length of coverage by
29% from 203 to 261 Mb, and the average signal intensity at
the TSS increased by 50%, similar to quiescent satellite cells
(Liu et al., 2013). H3K27me3 binding increased at 402 promoters
and decreased at 124 promoters (Figure 3E). Notably, at the Flt3
locus, H3K27me3 was increased and expression decreased
(Figure S3G), consistent with the diminished lymphoid differenti-
ation potential of aged HSCs.
One well-known target of the PcG family during aging is
Cdkn2a (encoding p16INK4a), which showed progressive loss of
H3K27me3-associated repression and increased expression
with aging in neural stem cells (Molofsky et al., 2006). Increased
Cdkn2a is considered a primary indicator of cellular senescence
in virtually all tissues in mice and humans (Lo´pez-Otı´n et al.,
2013). However, HSCs represent a stark exception; our results
show that p16INK4a is a bivalent gene effectively repressed by
H3K27me3 in both 4mo and 24mo HSCs, and its expression
remains undetectable at either age (Figure S3H). These data
argue against the notion that loss of function of HSCs with age
is due to the acquisition of a senescent state linked to p16.
Considering the global changes of H3K4me3 and H3K27me3
with HSC aging, we reexamined the bivalent domains. The
results indicated that 335 bivalent domains disappear in old
HSCs, whereas 1,245 emerge, largely because a gain of both
H3K4me3 and H3K27me3 or H3K27me3 only (Figure 3F). The
genes that lose H3K27me3 are enriched for the category of
membrane protein, whereas the genes that gain H3K27me3
are enriched for glycoprotein and cell adhesion (Figure S3I and
Table S5).
HSC-Specific Methylome
We also examined DNA methylation changes with aging. Global
CpG hypomethylation associated with aging has been observed
inmany tissues and is thought to contribute to genome instability
and the risk of neoplastic transformation (Maegawa et al., 2010).
Here, we used whole-genome bisulfite sequencing (WGBS) and
generated 1,494 million (4mo HSCs) and 1,493 million (24mo(D) Genome browser view on the Oxr1 gene body. The boxed area shows an un
(E) Heat map of H3K27me3 density around promoters that show significantly dif
(F) Venn diagram showed bivalent domains change with HSC aging.
See also Figure S3.HSCs) reads; about 82.6% and 84.3%, respectively, were
aligned to the reference genome (mm9). Of all cytosines present
in the reference genome, about 93%of Cs and 99%of CGswere
covered in both data sets, with an average coverage of 46-fold
(4mo) and 50-fold (24mo).
Globally, the HSC methylome exhibited the DNA methylation
patterns in line with those observed in other mammalian cells
(Stadler et al., 2011). Low DNA methylation was found in CpG
islands (CGIs) and promoters, and high methylation was found
in gene bodies and repetitive elements (Figures 4A and S4A–
S4C). Bivalent domains showed the lowest DNA methylation
(5%; Figure S4D), which was consistent with the inverse correla-
tion of DNA methylation and H3K4me3 (Meissner et al., 2008). In
contrast, H3K36me3-enriched regions are associated with the
highest DNA methylation (94%), possibly because of Dnmt3a
and H3K36me3 interaction (Dhayalan et al., 2010). Interestingly,
the CGI methylation is diverse and dependent on the genomic or
epigenomic context (Figure S4E).
We also compared the HSC and ESC (Stadler et al., 2011)
methylomes. 5% of CGIs show differential methylation between
these two stem cell types, with 689 CGIs hypermethylated and
130 CGIs hypomethylated in HSCs (Figure 4B). Furthermore,
we identified differentially methylated regions (DMRs) between
HSCs and ESCs as a region of at least 100 bp in length wherein
consecutive CpGs show the same hyper- or hypomethylation
state. Analysis showed striking enrichment of positive TF regu-
lation for hypo-DMR genes and negative TF regulation for
hyper-DMR genes. Of ten well-known hematopoietic TFs (Wil-
son et al., 2010), all had hypomethylated promoter regions,
and their target binding sites were also hypomethylated. For
example, the Runx1 promoter is methylated in ESCs and unme-
thylated in HSCs (Figure 4C), and its binding sites showed a
strong bias toward hypomethylation in HSCs (Figure 4D). Alto-
gether, the general methylation pattern in different genomic
regions is conserved in HSCs, but the methylation of cell-type-
specific TFs and their binding sites is unique to HSCs.
Aging-Dependent DNAMethylation and Interaction with
Histone Modifications
In contrast to the age-associated hypomethylation observed in
somatic cells, HSCs showed methylation increasing with age
from 83.5% to 84.6% in old HSCs, which was consistent with
previous studies focused on CGIs (Beerman et al., 2013). We
observed a total of 448,166 differentially methylated CpGs
(DMCs; R20% difference), of which 38.5% were hypomethy-
lated (hypo-DMCs) and 61.5% were hypermethylated (hyper-
DMCs). For different genomic features (Table S6), a slightly
greater DNA methylation increase was observed for the gene
body, LINEs, and SINEs, whereas CGIs and promoters showed
balanced increases and decreases (Figure 5A). DNA encoding
for rDNA was a hotspot for hypo-DMCs (Figure 5B). CpGs with
an intermediate methylation ratio were more susceptible to
alterations than fully methylated or unmethylated CpGs (Fig-
ure S5A). We also found that increased H3K4me3 stronglyannotated promoter with H3K4me3.
ferent H3K27me binding with age.
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Figure 4. HSC-Specific Methylome
(A) Violin plot showing DNA methylation ratios in
different genomic features. The thickness of the
bars indicates densities of CpGs at the y axis ratio,
and the white circle indicates the median.
(B) Scatter plot for mean methylation ratio for all
the CpGs of each CGI in HSCs in comparison
ESCs. The x and y axes indicate the methylation
ratio of each CGI in HSC and ESC respectively.
The black dots represent loci that are not signifi-
cantly different between the cell types, and the red
stars represent the CpG Islands that exhibit cell-
type-specific methylation.
(C) Genome browser view showing the percentage
ofmethylation in the promoter of theRunx1 gene in
young and old HSCs and ESCs.
(D) Methylation ratios in HSCs versus ESCs of
Runx1 binding sites as mapped in mouse HPC7
hematopoietic progenitor cells. Black and red are
as denoted in (B).
See also Figure S4.
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spots for both hypo- and hyper-DMCs (Table S6), and decreased
H3K36me3 correlated with hypo-DMCs (Figure 5C).
To identify the genes or pathways subject to DNA methylation
alterations, we screened the methylome for DMRs. We identified
4,828 hypo- and 4,523 hyper-DMRs between 4mo and 24mo
HSCs that were associated with 2,253 and 2,071 genes, respec-
tively (Table S7). Calculating the Pearson correlation between
the methylation and gene expression changes, we discovered
that DMRs between the TSS and the 1 kb immediately down-
stream showed the highest correlation with gene expression
(0.312) followed by the DMRs in the promoters lacking CGIs
(0.250; Figure S5B). Hypo-DMR-associated genes are en-
riched for pathways in cancer and include Bcl2, Ptk2, Rb1,
Mll3, Runx1, Flt3l, Myc, Igf1, Igf1r, NFkb2, Tgfb3, and Tgfbr2.
In contrast, both hypo- and hyper-DMR genes are enriched in
old HSCs for cell adhesion and actin cytoskeleton, such as
Arpc1a, Ablim2, Cadm1, Cdh1, Col2a1, CD34, CD40, and
CD86 (Figure S5C and Table S7).
DNA hypermethylation on polycomb-targeted genes is a
hallmark of cancer and aging. Here, we compared H3K27me3-
marked genes in both young and old HSCs with the DMR
gene list. We found that 40% of hyper-DMR genes contain
H3K27me3marks, whereas 25% of hypo-DMR genes contained
H3K27me3, confirming that polycomb-targeted genes are hot-
spots for aging-related DNA methylation (Figure 5D). One
example is Nr4a2, a regulator of HSC quiescence (Sirin et al.,680 Cell Stem Cell 14, 673–688, May 1, 2014 ª2014 Elsevier Inc.2010), which gained methylation on the
H3K27me3-marked domain with age
and correlated with suppression of the
short isoform (Figure S5D). To examine
whether an epigenetic signature alone
might identify potential biomarkers of
aging, we identified 50 genes that
showed concomitant DNA methylation
and histone H3K4me3 differences during
HSC aging (Figure 5E). These loci showeda particularly strong inverse correlation between their age-
related decrease in DNA methylation and their increased
H3K4me3 (64%; Figure S5E), but not all of them showed
increased gene expression (Figure S5F). These results indicate
that the epigenetic state may be used to predict aging indepen-
dent of gene expression.
Aging-Associated DNA Methylation Interferes with the
Transcriptional Network
Previous DNA methylation studies showed that hypomethylated
regions are usually associated with cell-specific regulatory
regions or TF binding sites (Hodges et al., 2011; Stadler et al.,
2011; Ziller et al., 2013). To determine whether the methylation
states in such regulatory regions change with HSC aging, we
examined the methylation ratio in the binding sites of five TFs
associated with HSC pluripotency, including Scl, Erg, Gata2,
Runx1, and Ldb1 (Wilson et al., 2010). Although basal methyl-
ation levels for these TF binding sites in HSCs are low (Fig-
ure S6A), methylation at Gata2 and Ldb1 binding sites are further
reduced with age (Figure S6B). This led us to further test whether
aberrant DNA methylation disrupts the HSC transcriptional
networks more broadly. We compiled genome-wide binding
sites of more than 150 TFs found in a variety of blood lineages
(>10) and compared them with DMRs identified in young and
old HSCs. The results revealed that hypo-DMRs are significantly
enriched for Ring1b, Scl, Gata1, Ldb1, and Runx1 binding sites
in old HSCs but not for Rad21 binding sites, which served as a
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Figure 5. HSC Methylome Alterations with Aging
(A) Plots show the degree of differential methylation in young versus old HSCs and the relationship between the local CpG density (blue). The top left plot shows all
DMCs in old HSCs defined as CpGs that are%20% less methylated andR20%more methylated. The other plots show DMCs located within different genomic
features.
(B) The percentage of hyper- (red) or hypo- (blue) DMCs in different genomic features.
(C) Interaction of DNA methylation and histone modifications. The percentage of DMCs in the indicated epigenetic features and their alterations with aging are
also shown.
(legend continued on next page)
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Lyl1, Gata2, Runx1, Lmo2, Fli1, and Erg have been suggested
to form a central transcription network that regulates HSC plurip-
otency (Wilson et al., 2010). Therefore, hypomethylation of the
binding sites for some of these factors or related family members
may play a role in reinforcing the self-renewal program in HSCs.
In parallel, hyper-DMRs are highly enriched for Pu.1, Fli1, Gfi1,
and Erg binding sites in old HSCs (Figure 6B). Among them, bind-
ing sites of Pu.1, which promotes HSC differentiation, showed
hypermethylation with the highest statistical significance (Fig-
ure 6C). Given that mutation or deletion of PU.1 is leukemogenic
(Cook et al., 2004), hypermethylation of its binding sites may
increase the risk for myeloid leukemia.
We also examined changes with age in methylation of can-
yons, which comprise around 1,100 large regions with low
methylation enriched for genes involved in transcriptional regula-
tion (Jeong et al., 2014). Hypomethylation is 25% to 28% more
frequent at inner edges of canyons, whereas hypermethylation
is 25%more frequent at outside edges (Figure 6D). Furthermore,
canyons with more hypomethylated DMCs are associated with
greater H3K4me3 coverage, whereas canyons with more hyper-
methylated DMCs show a distinct shift in H3K27me3 occupancy
characterized by both a substantial decline in partial coverage
(spanning < 25% of canyon length) and an increase in broader
H3K27me3 coverage (spanning > 90% of canyon length; Fig-
ure 6E). This is similar to the behavior of canyons after Dnmt3a
KO (Jeong et al., 2014).
All of these findings suggest that DNA methylation is a critical
layer of epigenetic regulation controlling HSC aging and under-
score some of the similarities between the epigenetic changes
with aging and those in Dnmt3a knockout HSCs.
Methylation Alterations Identify HSC Regulators and
Age-Associated Phenotypes
To determine whether changes in DNAmethylation were likely to
affect HSC function, we compared DMR genes with HSC
myeloid and lymphoid fingerprint genes. Strikingly, of HSC
fingerprint genes, 70% showed hypomethylation (Table S7),
which correlated with their increased expression (0.45; Figures
7A and S7A). Hypermethylation and decreased expression was
also observed on a subset of HSC fingerprint genes. To test
whether their decreased expression might explain HSC aging
phenotypes, we selected the imprinted gene Slc22a3 encoding
a solute carrier family member (Gru¨ndemann et al., 1998), for
further characterization (Figure 7B). To examine its function,
we transduced progenitors from young mice with a retroviral
microRNA (miRNA) knockdown construct. After 2 days of cul-
ture, transduced cells were sorted for quantitative RT-PCR
(qRT-PCR) in order to confirm a knockdown efficiency of
about 60% (Figure 7C), mimicking its expression change in
old HSCs. Although transplantation showed knockdown of
Slc22a3 did not affect engraftment, there were a greater propor-
tion of myeloid cells generated from Slc22a3 knockdown HSCs(D) Venn diagram showing the overlap of DMR genes with polycomb repressed
(E) Heat map of DNA methylation, H3K4me3 signal, and expression values for 50
where there is coexistence of differential H3K4me3 and DNA methylation. For H3
no methylation. For gene expression, red denotes upregulation and white denote
See also Figure S5.
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contribute to the myeloid-biased differentiation of old HSCs.
MDS is a hematologic disorder that increases dramatically
with age. We considered whether some of the changes asso-
ciated with normal HSC aging were associated with MDS. We
examined 66 MDS-related genes as defined by IPA. Of these,
21 contained a DMR (p = 1 3 1016), and their methylation
changes were generally inversely correlated with gene-
expression changes (Figure 7E). Five contained both hypo-
and hyper-DMRs, such as Hspa1a (Figure S7B). Notably, the
gene for splicing factor Sf3b1 contains a hyper-DMR at its TSS
region and shows decreased expression. Somatic mutation of
this gene has been found in 20% of MDS patients (Papaemma-
nuil et al., 2011). The disordered methylation on those MDS-
associated genes may contribute to the development of this
disease.
DISCUSSION
In summary, we present a comprehensive report of the transcrip-
tome and epigenetic signatures, including DNA methylation and
three histone modifications, of highly purified young and old
HSCs, which can serve as a resource for both normal and aging
adult stem cell studies. The epigenetic alterations are closely
correlated with the phenotypic and functional changes that
have been documented for HSCs, namely the increased HSC
self-renewal, diminished differentiation potential, and biased
ratio of myeloid versus lymphoid differentiation. Although not
directly pathological, the epigenetic changes we observe clearly
provide a cellular environment conducive to age-related pathol-
ogies, such as MDS and leukemia, as outlined below.
Age-Related Changes Suggest Reduced TGF-b
Signaling
Our analyses of the transcriptome of young and old HSCs
strikingly implicate TGF-b as likely to be among the most signif-
icant contributors to the functional age-related declines that
occur in this stem cell type with age. Although decreased TGF-
b signaling has been implicated in aging of cardiac and neural
tissue (Blaney Davidson et al., 2005; Loffredo et al., 2013), we
observed genes involved in specific signaling modules that are
most likely mediating the altered TGF-b response. In the context
of HSCs, we are inferring responses to stimuli that are most likely
initiated by the niche based on the large number of dysregulated
TGF-b genes.
For each step of the TGF-b1 signaling pathway, there are a
number of differentially expressed genes in aging HSCs. For
example, genes involved in ligand activation or bioavailability
were decreased, such as matrix metalloproteases mmp-2 and
mmp-9 (Yu and Stamenkovic, 2000). We also observed
decreased expression of the gene for Smad6, which interferes
with phosphorylation of Smad2 (Imamura et al., 1997) and
Smad cofactors p300, Crebbp, and Atf3. Given these data, asgenes in HSCs.
potential HSC aging markers. Each row represents a gene-associated region
K4me3 and DNA methylation, red denotes high methylation and white denotes
s downregulation.
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Figure 6. DNA Methylation Changes Interact with Transcriptional Network
(A) Hypo-DMRs are enriched for the indicated TF binding sites. Parentheses identify the cell type or cell line in which the TF binding sites were originally identified.
MKP, megakaryocyte progenitors; MEL, murine erythroleukemia cell line.
(B) Hyper-DMRs are enriched for TF binding sites in distinct blood lineages. Parentheses identify the cell type or cell line in which the TF binding sites were
originally identified. FLDN1_T, fetal liver DN1 T cell; Mac, macrophage; Mast, mast cells; MLL, MLL/ENL-expressing preleukemia cells; MEL, murine eryth-
roleukemia cell line.
(C) Scatter plot comparing the methylation ratio for all the Pu.1 binding sites identified in the HPC7 cell line between 4mo and 24mo HSCs. Red symbols indicate
binding sites with methylation ratios significantly changed between 4mo and 24mo HSCs.
(D) Average number of CpGs in DNA methylation canyon regions differentially methylated between 4mo and 24mo HSCs. Canyons are defined in 12mo HSCs.
DMCs counts are normalized by region length. Canyon core, region inset by 500 bp on each edge; inner and outer edge, 500 bp regions inside and outside canyon
edges, respectively. Error bars represent mean ± SEM. **p < 0.01 and ***p < 0.005 (Student’s t test).(E) H3K27me3 (left) and H3K4me3 (right) peak coverage
(legend continued on next page)
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on HSC function (Fan et al., 2002; Jacobsen et al., 1995), further
study of the role of TGF-b signaling in HSC aging is warranted.
Significance of the Altered Ribosomal Gene
Transcription
In the transcriptome, epigenome, andmethylome data, we found
that genes included in the GO category ribosome were a prom-
inent target of aging. In particular, the decreased ribosomal
protein gene pre-mRNA levels suggest more efficient splicing
and possibly translation. Even though aged HSCs are not more
in cycle than young HSCs (Chambers et al., 2007b; Rossi
et al., 2005), they may be more activated. Intriguingly, defects
in ribosome biogenesis have been linked to bone marrow failure
syndromes associated with a risk of developing malignancies,
such as Diamond-Blackfan anemia (Narla and Ebert, 2010). In
addition, ribosomal biogenesis has repeatedly been linked to
aging in model organisms (Curran and Ruvkun, 2007; Grewal,
2009; Hamilton et al., 2005; Pan et al., 2007) but not yet in
mammals. Our data suggest that a reexamination of the role
of the ribosome in mammalian stem cell aging should be
undertaken.
Consistency of HSC Aging with General Organismal
Aging
Our observations regarding the increase in H3K4me3 peaks and
the increased length of many of the peaks is striking in the
context of recent observations in C. elegans where mutation of
genes involved in H3K4 methylation increased longevity (Greer
et al., 2010). This phenomenon was dependent on a histone
demethylase (Greer et al., 2011), indicating that sustained
H3K4 methylation activity promotes aging. Although we do not
identify loss or gain of H3K4 methyltransferases, the accumula-
tion of H3K4me3 with age, particularly on genes in which H3K4
trimethylation is already broad, most likely contributes to the
dysfunction of HSCs in the older animals. Notably, the genes
associated with increased H3K4me3 breadth are specifically
those associated with stem cell self-renewal and loss of differen-
tiation capacity. Thus, the increase of this activating mark on
these particular genes may be linked to the functional changes
that occur in aged HSCs. We reanalyzed data from a recent
study on aging ofmuscle satellite cells (Liu et al., 2013) and found
that H3K4me3 length also increased by about 5% with age
(data not shown). It will be important to extend these observa-
tions of H3K4me3 to other aging systems and identify the critical
targets and mechanisms.
Relationship between Normal HSC Aging and Myeloid
Malignancies
MDS and AML are increasingly common with age. Although
heterogeneous, both of these diseases are marked by impeded
differentiation and a shift toward myeloid output. Our data
suggest that, even in the absence of discernable mutations, ag-density of canyons relative to aging DMCs. Density of peaks in 4mo HSCs at c
H3K4me3 peaks alone. H3K27me3 consists of any peak region containing H3K2
More Hypo and Hyper indicate canyons with greater numbers of hypomethylate
See also Figures S6 and S7.
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predisposition to MDS and myeloid malignancies. For example,
we see that expression of genes for key the epigenetic regulators
Dnmt3a and Ezh2 (both of which are found mutated in MDS
and AML) are slightly but significantly downregulated with age.
We also see that HSC-specific genes such as Gata2 and
Hmga2 are hypomethylated and upregulated and that binding
sites of TFs associated with differentiation, such as Pu.1, tend
to become hypermethylated, whereas sites associated with
factors involved in stem cell function (e.g., Scl) tend to be hypo-
methylated. Finally, we showed that the edges of DNA methyl-
ation canyons are highly dynamic in a manner concordant with
loss of Dnmt3a function (Jeong et al., 2014; Challen et al.,
2012), the mutation of which is associated with hematologic
malignancies (Ley et al., 2010; Yan et al., 2011). Although our
data cannot distinguish cause and effect with regard to these
epigenetic changes with age, together they point to a stem cell
state in which self-renewal is reinforced and differentiation is
impeded—a cellular milieu likely to be conducive to transforma-
tion events.
Abating the Effects of Age
By using whole-genome analyses, we showed that concerted
epigenetic changes may contribute to decreased differentiation
and increased stem cell self-renewal. These data also show that
the impact of epigenetic changes on aging is consistent,
suggesting the possibility that some of the effects might be
abated. Although aging is often regarded as an inexorable and
irreversible process, emerging views suggests that the aging
clock can be experimentally manipulated. Altogether, the find-
ings here may allow the development of novel approaches to
modulate HSC function.
EXPERIMENTAL PROCEDURES
Animals
C57BL/6 male mice were purchased from the National Institute for Aging and
maintained at the Baylor College of Medicine Animal Care Facility under Inter-
national Animal Care and Use Committee and institutional guidelines. None of
the animals exhibited overt signs of pathology when sacrificed. We chose
24 months because this time point presages significant mortality increase
and healthspan decline.
HSC Purification and Flow Cytometry
HSCswere purified frombonemarrow ofmice either 4 or 24months of age. For
all experiments, HSCs were purified as Hoechst SP-KLS and CD150+ cells
(see the Supplemental Experimental Procedures). Bone marrow cells were
stained for 90 min with Hoechst, magnetically enriched for cells with c-expres-
sion, stained with additional antibodies, and then subjected to flow cytometric
cell sorting. Purity was typicallyR 95%.
RNA Sequencing
Batches of approximately 70,000 HSCs and 1 million B and Gr cells were
sorted with fluorescence-activated cell sorting. RNA was isolated with the
RNeasy Micro Kit (QIAGEN). Paired-end libraries were generated by with Illu-
mina TruSeq RNA Sample Prep Kit. Illumina HiSeq was used for sequencinganyons subset by normalized counts of aging DMCs. H3K4me3 consists of
7me3, including bivalent (co-occupancy by H3K4me3) and H3K27me3 alone.
d or hypermethylated DMCs, respectively.
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Figure 7. DNA Methylation Regulates HSC Function and Contributes to Age-Related Diseases
(A) The correlation between gene expression changes andmethylation alterations for HSC fingerprint genes with DMRs. The x axis denotes the DMRmethylation
ratio difference, and the y axis denotes the log2 fold change of FPKM value for the gene. The circles mark the gene with names aside.
(legend continued on next page)
Cell Stem Cell
Epigenome Dysregulation in Aging HSCs
Cell Stem Cell 14, 673–688, May 1, 2014 ª2014 Elsevier Inc. 685
Cell Stem Cell
Epigenome Dysregulation in Aging HSCswith a paired-end sequencing length of 100 bp. For analysis, the alignment
was performed with the RNA-seq unified mapper, which first tries to map
reads to genome and transcriptome by Bowtie, and then the reads unmapped
to genome are handed to Blat for additional mapping. The information from the
three mappings was merged into one mapping. Then, the multiplied mapped
reads are discarded. The gene annotations used for transcriptome alignment
include standard known-gene models (see the Supplemental Experimental
Procedures). Differential expression was performed with DESeq. We used
DAVID to examine these differentially expressed genes for functional enrich-
ment in GO terms, KEGG Pathways, and SP_PIR_KEYWORDS. The unbiased
gene-set enrichment analysis was performed with Gene Set Association
Analysis sequencing (http://gsaa.unc.edu), which ranks all genes by DESeq
differential test p values and examines enrichment of all gene sets in the
Molecular Signatures Database and several manually created hematopoiesis
fingerprint gene sets.
ChIP Sequencing
ChIP-seq was performed with 50,000 to 100,000 HSCs, B cells, and Gr cells
(see the Supplemental Experimental Procedures). ChIP-seq DNA was made
into sequencing libraries with ThruPLEX-FD (Rubicon). Sequencing was per-
formed on an Illumina HiSeq 2000. The reads are mapped to mouse genome
mm9 with SOAP2 by allowing at most two mismatches for 50 bp short reads
and at most four mismatches for 100 bp short reads. Only uniquely mapped
reads were retained. The reads from each biological replicate are fed as a
treatment file into themodel-based analysis of ChIP-seq data (MACS) program
in order to find the peaks.
Whole-Genome Bisulfite Sequencing
300 ng genomic DNA was isolated from HSCs and fragmented with a Covaris
sonication system (Covaris S2). Libraries were constructed with Illumina
TruSeq DNA kit, ligated, and bisulfite-treated with the EpiTect Kit (QIAGEN).
After determining the optimized PCR cycle number for each samples, a
large-scale PCR reaction (100 ml) was performed (Gu et al., 2011). PCR
products were sequenced with Illumina HiSeq sequencing systems. The
WGBS data analyses were based on the model-based analysis of bisulfite
sequencing (Sun et al., 2014) (http://code.google.com/p/moabs/).
Statistical and Bioinformatic Analysis
See the Supplemental Experimental Procedures.
ACCESSION NUMBERS
Data sets were deposited to the NCBI Gene Expression Omnibus under
accession number GSE47819. Data and genome browser tracks can also be
found at http://www.aginghscepigenome.us.
SUPPLEMENTAL INFORMATION
Supplemental Information contains Supplemental Experimental Procedures,
seven figures, and seven tables and can be found with this article online at
http://dx.doi.org/10.1016/j.stem.2014.03.002.(B) University of Southern California browser track showing expression (green) and
between 4mo and 24mo HSCs. H3K4me3 signal is shown in pink for the TSS reg
(C) qRT-PCR to show that Slc22a3 was knocked down by miRNA construct.
transduced with retroviral miRNA construct. After in vitro culture for 2 days, 20,00
0.01 and ***p < 0.005 (Student’s t test).
(D) The left figure shows the contribution of retrovirally transduced donor HSCs
percentage of indicated lineages within the retrovirally transduced donor HSC-
(8 weeks). Myeloid cells (Mye) were defined with the markers Gr1+ and Mac1+, B c
bars represent mean ± SEM. **p < 0.01 and ***p < 0.005 (Student’s t test).
(E) Venn diagram showing MDS genes with hyper- or hypo-DMRs. Regions with
(F) Model for functional and epigenetic alterations with HSC aging. DNA hypometh
HSC activation state. DNA hyper- or hypomethylation in master TF binding site
differentiation.
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